Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft vs Host Disease”

589 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 589 results

Not applicableEnded earlyNCT00253552
What this trial is testing

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
OHSU Knight Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00003335
What this trial is testing

Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Case Comprehensive Cancer Center 44
Testing effectiveness (Phase 2)Study completedNCT00031148
What this trial is testing

Keratinocyte Growth Factor to Prevent Acute GVHD

Who this might be right for
Graft-vs-Host Disease
FDA Office of Orphan Products Development 72
Early research (Phase 1)WithdrawnNCT04280471
What this trial is testing

Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host Disease

Who this might be right for
Acute Graft Versus Host DiseaseGastrointestinal Tract Acute Graft Versus Host DiseaseSevere Gastrointestinal Tract Acute Graft Versus Host Disease+1 more
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)UnknownNCT03631589
What this trial is testing

MSC for Severe aGVHD

Who this might be right for
Steroid-resistant Severe aGVHD
Fujian Medical University 50
Testing effectiveness (Phase 2)UnknownNCT06473909
What this trial is testing

Combination of Steroid and Humanized CD25 Monoclonal Antibody as First-line Therapy for aGVHD

Who this might be right for
Acute Graft Versus Host Disease
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT04061876
What this trial is testing

First Line Therapy for High Risk Acute GVHD

Who this might be right for
aGVHDStem Cell Transplant Complications
Chinese PLA General Hospital 198
Testing effectiveness (Phase 2)WithdrawnNCT03862079
What this trial is testing

Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum Antibiotics

Who this might be right for
Graft-versus-host Disease Prevention
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01757197
What this trial is testing

Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)

Who this might be right for
Glucocorticosteroid Refractory Acute GVHD
Weill Medical College of Cornell University 2
Testing effectiveness (Phase 2)UnknownNCT01240525
What this trial is testing

Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
University College, London 114
Not applicableEnded earlyNCT00608517
What this trial is testing

Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)WithdrawnNCT00578591
What this trial is testing

Rituximab for GVHD

Who this might be right for
Graft vs Host DiseaseAlogenic Hematopoietic Transplant
Baylor College of Medicine
Large-scale testing (Phase 3)WithdrawnNCT00349518
What this trial is testing

Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic Leukemia
Bristol-Myers Squibb
Very early researchUnknownNCT04285424
What this trial is testing

FMT for Steroid Resistant Gut Acute GVHD

Who this might be right for
Stem Cell Transplant ComplicationsAcute Graft-Versus-Host DiseaseFecal Microbiota Transplantation
Affiliated Hospital to Academy of Military Medical Sciences 30
Post-approval studies (Phase 4)Active Not RecruitingNCT06462469
What this trial is testing

Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease

Who this might be right for
Steroid-refractory Acute Graft Versus Host Disease
Novartis Pharmaceuticals 36
Not applicableUnknownNCT04622475
What this trial is testing

Efficacy and Safety of FMT Capsule Treating Steroid-refractory GI-aGvHD

Who this might be right for
Steroid-refractory Gastrointestinal Acute Graft Versus Host Disease
Nanfang Hospital, Southern Medical University 10
Testing effectiveness (Phase 2)Study completedNCT01251575
What this trial is testing

Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Adult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more
Fred Hutchinson Cancer Center 77
Early research (Phase 1)Ended earlyNCT00376519
What this trial is testing

Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT02997280
What this trial is testing

Ruxolitinib for Steroid-refractory GVHD

Who this might be right for
Graft Vs Host Disease
St. Petersburg State Pavlov Medical University 75
Large-scale testing (Phase 3)Looking for participantsNCT06756152
What this trial is testing

Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis

Who this might be right for
Biphenotypic Acute LeukemiaAcute Lymphoblastic LeukemiaMyeloblastic Leukemia+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 50
Next Page